http://orcid.org/0000-0002-1459-2559
Figures
Abstract
Background
The overlap of malaria and chronic hepatitis B (CHB) is common in endemic regions, however, it is not known if this co-infection could adversely influence clinical and immunological responses. This study investigated these interactions in pregnant women reporting to antenatal clinics in Ghana.
Methods
Clinical parameters (hemoglobin, liver function biomarker, peripheral malaria parasitemia, and hepatitis B viremia) and cytokine profiles were assayed and compared across four categories of pregnant women: un-infected, mono-infected with Plasmodium falciparum (Malaria group), mono-infected with chronic hepatitis B virus (CHB group) and co-infected (Malaria+CHB group).
Results
Women with Malaria+CHB maintained appreciably normal hemoglobin levels (mean±SEM = 10.3±0.3 g/dL). That notwithstanding, Liver function test showed significantly elevated levels of alanine aminotransferase, aspartate aminotransferase and total bilirubin [P<0.001 for all comparisons]. Similarly, the Malaria+CHB group had significantly elevated pro-inflammatory cytokines, including tumour necrosis factor alpha (TNF-α), interleukin (IL)-1β, and IL-6 [P<0.05 for all comparisons]. In women with Malaria+CHB, correlation analysis showed significant negative association of the pro-inflammatory cytokines responses with malaria parasitemia [IL-1β (P<0.001; r = -0.645), IL-6 (P = 0.046; r = -0.394) and IL-12 (P = 0.011; r = -0.49)]. On the other hand, the pro-inflammatory cytokine levels positively correlated with HBV viremia [TNF-α (P = 0.004; r = 0.549), IL-1β (P<0.001; r = 0.920), IL-6 (P<0.001; r = 0.777), IFN-γ (P = 0.002; r = 0.579), IL-2 (P = 0.008; r = 0.512) and IL-12 (P<0.001; r = 0.655)]. Also, for women in the Malaria+CHB group, parasitemia was observed to diminish HBV viremia [P = 0.003, r = -0.489].
Citation: Anabire NG, Aryee PA, Abdul-Karim A, Quaye O, Awandare GA, Helegbe GK (2019) Impact of malaria and hepatitis B co-infection on clinical and cytokine profiles among pregnant women. PLoS ONE 14(4): e0215550. https://doi.org/10.1371/journal.pone.0215550
Editor: Jason Blackard, University of Cincinnati College of Medicine, UNITED STATES
Received: January 5, 2019; Accepted: April 3, 2019; Published: April 19, 2019
Copyright: © 2019 Anabire et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: This work was supported by Nsoh Godwin Anabire’s MPhil fellowship from a World Bank African Centres of Excellence Grant (ACE02-WACCBIP: Awandare) and funds from the University for Development Studies, Tamale. Views expressed in this publication are those of the author(s) and not necessarily the funders.
Competing interests: The authors have declared that no competing interests exist.
Background
Coinfections are increasingly being recognized as common risk factors that may contribute to the increased burden of morbidity in pregnancy. In many endemic setting, the overlap of chronic hepatitis virus (HBV) and P. falciparum infections is common, and an increased prevalence, from 0.7% to 1.7%, of this co-infection has been reported among pregnant women in Ghana [1, 2]. The disease causing pathogens share a common intra-hepatic niche, and each may independently cause liver function test abnormalities [3–9]. Immunologically, both pathogen may also overlap, as each is observed to mainly trigger T helper type 1 (Th1) cytokine responses [10–14]. P. falciparum causes anemia by reducing red cell counts, while HBV is postulated to increase hemoglobin (Hb) levels by increasing the release of erythropoietin from regenerating hepatic tissues [15–17]. Thus, it may be logical to postulate that HBV could compensate for the effect of P. falciparum on Hb levels in co-infection state.
Anemia, liver dysfunctions and cytokine imbalance (towards Th1) in pregnancy are associated with significant morbidity and mortality for both the mother and the newborn [18–20]. Though physiologic and biochemical (high serum alkaline phosphatase) changes in pregnancy are often mistaken for signs of liver disease, levels of aminotransferases remain normal, while bilirubin is below normal range [21, 22]. Therefore, elevated levels of aminotransferases and bilirubin in pregnancy gives evidence of liver dysfunction and damage. In normal pregnancy, Th1 and T helper type 2 (Th2) responses are tightly regulated throughout the trimesters [23], but excess of Th1 responses are observed to affect pregnancy outcomes [24].
Although P. falciparum and HBV are routinely diagnosed in pregnant women on antenatal visits, the hematological and hepatological impact of co-infection has received little attention mainly because: falciparum malaria is curable and does not cause chronic infections, and liver functions tests are not conducted. This study therefore evaluates the influence of co-infection on clinical (Hb levels and liver function) and cytokine profiles in pregnant women. The results of the study provide important information that would be useful in guiding policy/decisions on P. falciparum/HBV diagnosis, treatment and management in pregnant women in endemic countries.
Methods
Study sites and participants
Pregnant women were recruited on their first antenatal visit at various hospitals and health centres in the Northern Region of Ghana, from October 2016 to February 2017. The study areas were Tamale metropolis and Central Gonja District. Recruitments were done at Tamale Teaching Hospital, Tamale Central Hospital, Tamale West Hospital and Bilpella Health Centre, all located in Tamale metropolis. In the Central Gonja District, the participants were recruited from Sankpala and Kosawgu Health Centres. A total of 2071 pregnant women were screened for P. falciparum and HBV infections. Following the exclusion of women with documented chronic alcoholism, diagnosed eclampsia/preeclampsia, chronic degenerative diseases, use of hepatotoxic or immunosuppressant drugs, sickle cell trait, and other viral (HIV, hepatitis C) and parasitic (amebiasis, hydatid cyst, ascaris and schistosomiasis) infections, 257 were enrolled and used for this study. Also, demographic and obstetric data were obtained from the participants’ antenatal care log books.
Ethical consideration
Informed consent was obtained from each study participant after an explanation of the purpose, benefits, and risks of the study was provided. The ethics committee of the Tamale Teaching Hospital approved the study (Approval ID: TTHERC/21/04/16/02).
Clinical and DNA samples
Stool and urine samples were collected and screened for the other parasitic infections that are listed in the exclusion criteria. Venous blood samples (5 mL) were collected and a portion (4 mL) was processed for serum. The serum was used for the diagnosis of CHB, liver function test and quantification of cytokines. The remaining blood (1 mL) was used for diagnoses of malaria, and screening of sickle cell trait and the other viral infections captured in the exclusion criteria. DNA was extracted, from both whole blood and serum, with the QIAamp DNA mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol. The extracted DNA samples were used in the PCR assays for plasmodium species detection and HBV quantification.
Clinical laboratory analyses
CareStart histidine-rich protein 2 (HRP-2) test cassettes (Access Bio Inc., New Jersey, USA) and hepatitis B surface antigen (HbsAg) test strips (Ark Biotech., Shanghai, China) were used for rapid diagnoses of malaria and hepatitis B respectively. Both tests were performed in accordance with the manufacturer’s recommendations.
Malaria parasite densities were determined by microscopy, performed by two independent World Health Organization (WHO) certified microscopists based on WBC count of 8,000 cells/μL [25].
Hemoglobin was quantified by the cyanomethemoglobin (Drabkin’s) method, using BS-3000 Chemistry Analyzer (Sinnowa Medical Science and Technology Co. Ltd, Nanjing, China). Five (5) uL of EDTA blood and standards were thoroughly mixed in separate plain tubes containing 5 ml Drabkin’s solution (Sigma-Aldrich, St. Louis, USA) and allowed to incubate at room temperature for 30 minutes. Absorbances were read at 540 nm and the hemoglobin concentrations were obtained using a calibration curve. Samples were measured in duplicates, and those with standard deviations <15% were used in the data analysis.
Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and total bilirubin (Tbil) were measured using the Selectra Pro X5 automated chemistry analyzer (Elitech Group of Companies, Puteaux, France). The instrument was calibrated and standardized daily before the measurements were obtained. Samples were quantified in duplicates and duplicate samples with <15% percentage coefficient of variation were considered.
PCR for plasmodium species detection
Plasmodium species were detected using a previously described nested PCR method [26, 27]. In the first PCR, the small sub-unit ribosomal genes of plasmodium were amplified using genus-specific forward and reverse primers. In the second PCR, species-specific forward and reverse flanking primers were used for detection of P. falciparum, P. vivax, P. malariae, and P. ovale. For both rounds of PCR, the total reaction volume was 20 μL, containing 2.5 μL of 10X PCR buffer, 1.5 μL of 25 mM MgCl2, 0.5 μL of 10 μM primers, 0.5 μL of 10 μM deoxynucleotides and 0.2 μL of 1 U Taq DNA polymerase (Qiagen, Hilden, Germany). The PCR products were visualized on 2% agarose gel containing 1.5 μL ethidium bromide, and the plasmodium species were identified by respective band sizes.
PCR for quantification of HBV DNA
A PCR assay that was described previously was used to amplify a 98 base pair product of the S-gene of HBV genome [28]. The total reaction volume of 10 μL consisted of 0.5 μL each of 10 μM forward and reverse primers, 5 μL Low ROX PerfeCTa syber green SuperMix (Quanta Biosciences Inc., Gaithersburg, USA), 2 μL nuclease free water and 2 μL DNA. Thermal cycling was performed on QuanStudio 5 TaqMan quantitative real-time PCR system (Thermofisher Scientific, New Jersey, USA). Cycling conditions were: initial denaturation at 95°C for 15 minutes, followed by 40 cycles of denaturation at 94°C for 15 seconds, annealing at 55°C for 30 seconds, and elongation at 68°C for 30 seconds. The AcroMetrix HBV High Control (Thermofisher Scientific, New Jersey, USA) with viral load of 7.43 log (10) IU/mL was serially diluted with nuclease free water to four different dilutions of 1/5, 1/25, 1/125, and 1/625 with final concentrations of 6.82, 6.17, 5.52 and 4.87 log (10) IU/mL, respectively. Before assaying the samples, the study assessed the performance of the assay by comparing it with the Roche Molecular Systems for detection of HBV DNA. The co-efficient of variation between both assays was <5%.
Levels of human anti-HBV virus core antibody (HBcAb)
Sera of pregnant women who tested positive for HBV infection by PCR were each tested for the presence of HBcAb-IgG and HBcAb-IgM using IgG-HBcAb ELISA kit and IgM- HBcAb ELISA kit (MyBioSource Inc., San Diego, USA), respectively, following the manufacturer’s protocols. Absorbances were read at 450 nm using a Varioscan lux plate reader (Thermofisher Scientific, New Jersey, USA). Each sample was tested in duplicate, and those with standard deviations <15% were considered. The results obtained were interpreted in accordance with the manufacturer’s recommendations, and all samples tested were IgG positive and IgM negative.
Cytokine analysis
Serum samples were thawed and clarified by centrifugation at 14, 000 rpm for 10 minutes and used to determine the levels of 10 cytokines; interferon gamma (IFN-γ), Tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-6, IL-12, IL-2, IL-10, IL-4, IL-5 and IL-13. The cytokines were measured on the xMAP Technology platform (Luminex Corporation, Austin, USA) using the magnetic beaded Milliplex MAP 13-plex kit (Merck, Darmstadt, Germany), and following the manufacturer’s protocol. Twenty-six samples of each category of the study participants were randomly selected for the assay. The samples were assayed in duplicates and those with <15% percentage coefficient of variation were included in the data analysis.
Statistical analysis
Categorical variables were presented as frequencies and percentages, and compared by Pearson’s chi-square test. Continuous parametric data were described as mean and standard deviation (SD) or standard error of mean (SEM), and compared by one-way analysis of variance (ANOVA) or Tukey's multiple comparisons test with Tukey's correction. Continuous non-parametric data were presented as median and interquartile range (IQR), and compared by Dunn's multiple comparison tests with Dunn’s correction. Correlation analyses were done by Spearman’s test.
Results
Infection statuses and obstetric information
Of the 257 women enrolled, 73 were uninfected, 80 were mono-infected with P. falciparum (Malaria group), 68 were mono-infected with HBV (CHB group), and 36 were co-infected with both pathogens (Malaria+CHB group). The infection statuses of the pregnant women were independent of age, gestation and gravidity (Table 1). All the women in the CHB and Malaria+CHB groups were IgG positive and IgM negative, which suggests that they had chronic HBV infections.
Hemoglobin levels
The mean Hb ± SEM was significantly higher in the CHB group (11.0 ± 0.2 g/dL) than the un-infected (10.2 ± 0.2 g/dL) and the Malaria group (10.0 ± 0.2 g/dL) (Fig 1). However, Hb levels were statistically similar between the CHB and Malaria+CHB groups (10.3 ± 0.3 g/dL), P = 0.129. In addition, a higher proportion of women with CHB had normal Hb levels (Hb ≥ 11g/dL) (χ2 = 12.47, P< 0.006, S1 Table).
Pair-wise differences between the groups was tested by the Tukey's multiple comparisons test with Tukey's correction, *P = 0.043, **P = 0.004. Horizontal bar with error bars represents the mean and standard error of mean respectively.
Serum levels of liver and inflammatory biomarkers
Compared with the other groups, the Malaria+CHB group had significantly elevated levels of the liver biochemical parameters including ALT (Fig 2A), AST (Fig 2B) and Tbil (Fig 2C). Similarly, the group had elevated serum levels of pro-inflammatory cytokines including TNF-α (Fig 3A), IL-1β (Fig 3B), and IL-6 (Fig 3C). However, compared with the other groups, anti-inflammatory cytokines including IL-10 (Fig 4A) and IL-4 (Fig 4B), were lower in women with Malaria+CHB. Women with Malaria and CHB had similar levels of the liver biomarkers and cytokines, except for significantly higher levels of IL-10 in the Malaria group (Fig 4A).
Dunn's multiple comparison tests for pair-wise differences in serum levels of (A) alanine aminotransferase (ALT), (B) aspartate amino transferase (AST), (C) total bilirubin (Tbil) and (D) alkaline phosphatase (ALP). Significant P-values were observed at *P < 0.05, **P < 0.01 and ****P < 0.0001. Horizontal bar with error bars represents the median and the interquartile range respectively.
Dunn's multiple comparison tests for differences in serum levels of (A) tumour necrosis factor alpha (TNF-α), (B) interleukin (IL)-1β, (C) IL-6, (D) interferon gamma (IFN-γ), (E) IL-2 and (F) IL-12. Statistical significance was observed at *P< 0.05, **P< 0.01 and **** P< 0.0001. Horizontal bar with error bars represents the median and the interquartile range respectively. n = number of samples of each category of the study participants assayed.
Dunn's multiple comparison tests for significant P-values in levels of (A) IL-10, (B) IL-4 (C) IL-5 and (D) IL-13. Statistical significance was observed at *P < 0.05, ** P < 0.01 and ***P < 0.001. Horizontal bar with error bars represents the median and the interquartile range respectively. n = number of samples of each category of the study participants assayed.
Correlation of pro-inflammatory cytokine responses with malaria or HBV intensity in co-infected cohorts
In women with Malaria+CHB, Levels of 3 out of the 6 pro-inflammatory cytokines negatively correlated with malaria parasitemia [IL-1β (P<0.001; r = -0.645), IL-6 (P = 0.046; r = -0.394) and IL-12 (P = 0.011; r = -0.49)]. That notwithstanding, parasitemia was similar between the Malaria+CHB and CHB groups (P = 0.304, Table 2). On the other hand, levels of all the pro-inflammatory cytokines positively correlated with HBV viremia [TNF-α (P = 0.004; r = 0.549), IL-1β (P<0.001; r = 0.920), IL-6 (P<0.001; r = 0.777), IFN-γ (P = 0.002; r = 0.579), IL-2 (P = 0.008; r = 0.512) and IL-12 (P<0.001; r = 0.655)], and viremia was significantly lower in the Malaria+CHB compared to the CHB group (P = 0.016, Table 2). Further analysis showed that malaria parasitemia negatively correlated with hepatitis B viremia in women with Malaria+CHB (P = 0.003, r = -0.489).
Discussion
Maternal anemia is an issue of important public health relevance. During pregnancy, women with Hb <11g/dL are diagnosed as anemic while those with Hb ≥ 11g/dL are considered to have normal level [29]. P. falciparum causes anemia by reducing red cell counts, HBV on the other hand is postulated to increase Hb levels by increasing the release of erythropoietin from regenerating hepatic tissues [15–17]. It is therefore logical that pregnant women with Malaria+CHB maintained intermediate levels of hemoglobin (above the Malaria group and un-infected, and below CHB group). This observation may suggest that in women with Malaria+CHB, activities of the plasmodium parasites in reducing red cell count may be compensated for by the activities of the virus, thus maintaining an appreciable hemoglobin concentration. The significant association of CHB with Hb ≥11g/dL further justifies the possible impact of HBV in increasing hemoglobin levels among the pregnant women. However, this might not necessarily translate into improved pregnancy outcomes, since cases of gestational diabetes, antepartum hemorrhage and preterm delivery are observed to be more frequent in pregnant women with CHB [30–32].
Relative to the un-infected (Figs 2 and 3), the increased serum levels of the liver function biomarkers and pro-inflammatory cytokines in the Malaria or CHB groups have been previously reported [3–6, 8–14]. In particular, elevated levels of IL-10 among the Malaria group is a common finding amongst African multigravidae mothers with P. falciparum infection [14, 33–35], and as such, the cytokine has been implicated in the immunopathology of placental malaria [36].
Similarity in levels of the liver biomarkers between women with Malaria and CHB may lend credence that the elevated levels in those with Malaria+CHB resulted from additive activities of both pathogens. The synergistic elevation in levels of the liver biomarker in the Malaria+CHB group may be attributed to immune factors that limit the infections at the liver-stage. Particularly, natural killer (NK) and natural killer T (NKT) cells which are abundantly available in the liver, interact with pathogens and initiate liver-stage cell-mediated immunity [37, 38]. For HBV infections, NK cells contribute to liver inflammation by tumor necrosis factor–related apoptosis-inducing ligand (TRAIL)-mediated death of hepatocytes, which is non-antigen–specific, and can be switched on by a milieu of cytokines [39]. Therefore, it is possible that, in women with Malaria+CHB, cytokines released in response to P. falciparum could further activate the apoptosis of HBV-infected hepatocytes, and exacerbate liver damage.
While peripheral levels of TNF-α, IL-1β and IL-6 were similar in women with Malaria and CHB, the pro-inflammatory cytokines were significantly increased in those with Malaria+CHB, which further suggests a possible additive effect of the infections. The correlation analysis with the Malaria+CHB group suggests that increased pro-inflammatory cytokine levels as a necessary immune response against malaria helped in reducing HBV intensity. This corroborates with studies indicating that P. falciparum malaria modulates viremia in chronic hepatitis B virus infection [40, 41]. IL-10 and IL-4 are key anti-inflammatory cytokines that regulate the activities of pro-inflammatory cytokines responses. Thus, the diminished peripheral levels of IL-10 and IL-4 in the women with Malaria+CHB may suggest susceptibility to cytokine imbalance (towards Th1). In particular, placental cytokine imbalance is noted to be associated with threatened abortion, recurrent spontaneous miscarriage, and preterm delivery [18, 42]. That notwithstanding, biased peripheral pro-inflammatory cytokine responses has been implicated with pregnancy complications [43, 44].
Limitations
A longitudinal approach on changes of Hb levels in the co-infected cohorts after clearance of P. falciparum would have been paramount in substantiating the compensatory effect of the viral infection. Again such an approach would have enabled us to see the kinetics of Malaria+CHB co-infection and to identify times when the markers of liver injury and inflammatory responses are enhanced. In addition, such an approach would have enabled us to substantiate our findings by profiling placental cytokines responses, malaria parasitemia and HBV viremia, and associating the results with pregnancy complications. Also profiling of innate immune cells and T-cell populations would have given a better insight of the effect of the co-infection on the immune response. Nonetheless, the current study provides evidence on the need to take into cognizance the possible deleterious impact of Malaria+CHB on pregnant women. In this regard, liver functions test which is important in guiding diagnosis and treatment of liver diseases in pregnancy must be readily accessible to pregnant women on ANC clinics.
Conclusion
Put together the findings suggests that Malaria+CHB could exacerbate inflammatory cytokine responses and increase susceptibility to liver injury among pregnant women in endemic settings.
Supporting information
S1 Table. Association between infection type and normal hemoglobin levels during pregnancy.
https://doi.org/10.1371/journal.pone.0215550.s001
(DOCX)
Acknowledgments
We thank the study participants, and the numerous health personnel at Tamale Metropolis and Central Gonja for their immense support.
References
- 1. Helegbe GK, Aryee PA, Mohammed BS, Wemakor A, Kolbila D, Abubakari AW, Askanda S, Alhassan R, Barnie C, Donkoh AA, and Ofosu E. Seroprevalence of Malaria and Hepatitis B Coinfection among Pregnant Women in Tamale Metropolis of Ghana: A Cross-Sectional Study. Canadian Journal of Infectious Diseases and Medical Microbiology. 2018;2018.
- 2. Anabire NG, Aryee PA, Abdul-Karim A, Abdulai IB, Quaye O, Awandare GA, and Helegbe GK. Prevalence of malaria and hepatitis B among pregnant women in Northern Ghana: Comparing RDTs with PCR. PloS one. 2019 Feb 6;14(2):e0210365. pmid:30726218
- 3. Mackillop L, and Williamson C. Liver disease in pregnancy. Postgrad Med J. 2010;86(1013):160–4. pmid:20237010
- 4. Nwosu DC, Nwanjo HU, Obeagu EI, Ibebuike JE, Ezeama MC, and Ihekireh . Changes in liver enzymes and lipid profile of pregnant women with malaria in Owerri, Nigeria. International Journal of Current Research and Academic Review. 2015;3(5):376–83.
- 5. Eldaim N, and Elbadawi E. The effect of malaria on biochemical liver function parameters in Sudanese pregnant women. Journal of Physiobiochemical Metabolism. 2012.
- 6. Woodford J, Shanks GD, Griffin P, Chalon S, and McCarthy J. The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study. Am J Trop Med Hyg. 2018.
- 7. Mahtab M-A, Rahman S, Khan M, Mamun A, and Afroz S. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh. Hepatobiliary Pancreat Dis Int. 2008;7(2):161–4. pmid:18397851
- 8. Tan H-H, Lui H-F, and Chow W-C. Chronic hepatitis B virus (HBV) infection in pregnancy. Hepatology international. 2008;2(3):370–5. pmid:19669267
- 9. Elefsiniotisa IS, Brokalakia H, Argyropoulosa E, Magaziotou I, Derdemezib A, Mihasa C, and Tsoumakasb K. Evaluation of liver enzymes in asymptomatic chronic hepatitis B virus infected pregnant women. Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology. 2013;26(1):59.
- 10. Sarin SK, Kumar M, Shrivastava S, Sinha S, and Pati NT. Influence of chronic HBV infection on pregnancy: a human model of maternofetal virus host interactions. Gastroenterology. 2011;141(4):1522–5. pmid:21867707
- 11. Saxena R, Chawla YK, Verma I, and Kaur J. Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population. The Indian journal of medical research. 2014;139(5):737. pmid:25027084
- 12. Kfutwah A, Mary JY, Lemen B, Leke R, Rousset D, Barré-Sinoussi F, Nerrienet E, Menu E, Ayouba A, and ANRS 1267 study team. Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women. PloS one. 2009;4(12):e8114. pmid:19956547
- 13. Ifeanyichukwu M, Okamgba O, Amilo G, and Nwokorie E. Peripheral parasitaemia and its association with plasma cytokines levels in malaria-infected pregnant women in Aba, Abia State, Nigeria. African Journal of Infectious Diseases. 2017;11(2):54–61. pmid:28670640
- 14. Nmorsi O, Isaac C, Ohaneme B, and Obiazi H. Pro–inflammatory cytokines profiles in Nigerian pregnant women infected with Plasmodium falciparum malaria. Asian Pacific Journal of Tropical Medicine. 2010;3(9):731–3.
- 15. Ifudu O, and Fowler A. Hepatitis B virus infection and the response to erythropoietin in end-stage renal disease. ASAIO journal. 2001;47(5):569–72. pmid:11575840
- 16. Simon P, Boffa G, Ang K, and Menault M. Polycythaemia in a haemodialyzed anephric patient with hepatitis. Demonstration of erythropoietin secretion (author's transl). La Nouvelle presse medicale. 1982;11(18):1401–3. pmid:7079159
- 17. Klassen DK, and Spivak JL. Hepatitis-related hepatic erythropoietin production. The American journal of medicine. 1990;89(5):684–6. pmid:2239989
- 18. Raghupathy R, and Kalinka J. Cytokine imbalance in pregnancy complications and its modulation. Front Biosci. 2008;13(1):985–94.
- 19. Joshi D, James A, Quaglia A, Westbrook RH, and Heneghan MA. Liver disease in pregnancy. The Lancet. 2010;375(9714):594–605.
- 20. Westbrook RH, Yeoman AD, Joshi D, Heaton ND, Quaglia A, O’Grady JG, Auzinger G, Bernal W, Heneghan MA, and Wendon JA. Outcomes of Severe Pregnancy‐Related Liver Disease: Refining the Role of Transplantation. American Journal of Transplantation. 2010;10(11):2520–6. pmid:20977643
- 21. Baheti R, Laddha P, and Gehlot R. Liver involvement in falciparum malaria–A Histo-pathological analysis. J Indian Acad Clin Med. 2003;4(1):34–8.
- 22.
Harinasuta T, and Bunnag D. The clinical features of malaria. Malaria: principles and practice of malariology Edited by Wernsdorfer WH, McGregor I London: Churchill Livingstone. 1988:709–34.
- 23. Mor G, Cardenas I, Abrahams V, and Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Annals of the New York Academy of Sciences. 2011;1221(1):80–7.
- 24. Saito S, Nakashima A, Shima T, and Ito M. REVIEW ARTICLE: Th1/Th2/Th17 and Regulatory T‐Cell Paradigm in Pregnancy. American journal of reproductive immunology. 2010;63(6):601–10. pmid:20455873
- 25.
World Health Organization. Routine examination of blood films formalaria parasites. In: World Health Organization, editor Basic Mala´riaMicroscopy, Learner’s guide Switzerland: WHO. 2010:69–76.
- 26. Snounou G, Viriyakosol S, Jarra W, Thaithong S, and Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Molecular and biochemical parasitology. 1993;58(2):283–92. pmid:8479452
- 27. Nsobya SL, Parikh S, Kironde F, Lubega G, Kamya MR, Rosenthal PJ, and Dorsey G. Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children. Journal of Infectious Diseases. 2004;189(12):2220–6. pmid:15181569
- 28. Garson J, Grant P, Ayliffe U, Ferns R, and Tedder R. Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. Journal of virological methods. 2005;126(1):207–13.
- 29. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011.
- 30. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver international: official journal of the International Association for the Study of the Liver. 2009;29 Suppl 1:133–9.
- 31. Tse KY, Ho LF, and Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. Journal of hepatology. 2005;43(5):771–5. pmid:16139923
- 32. Safir A, Levy A, Sikuler E, and Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver international: official journal of the International Association for the Study of the Liver. 2010;30(5):765–70.
- 33. Boström S, Ibitokou S, Oesterholt M, Schmiegelow C, Persson JO, Minja D, Lusingu J, Lemnge M, Fievet N, Deloron P, and Luty AJ. Biomarkers of Plasmodium falciparum infection during pregnancy in women living in northeastern Tanzania. PLoS One. 2012;7(11):e48763. pmid:23155405
- 34. Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, and Duffy PE. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. The Journal of infectious diseases. 2008;198(2):163–6. pmid:18500927
- 35. Boeuf P, Aitken EH, Chandrasiri U, Chua CL, McInerney B, McQuade L, Duffy M, Molyneux M, Brown G, Glazier J, and Rogerson SJ. Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transport. PLoS pathogens. 2013 Feb 7;9(2):e1003153. pmid:23408887
- 36. Suguitan AL Jr, Cadigan TJ, Nguyen TA, Zhou A, Leke RJ, Metenou S, Thuita L, Megnekou R, Fogako J, Leke RG, and Taylor DW. Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon. The American journal of tropical medicine and hygiene. 2003 Dec 1;69(6):574–81. pmid:14740871
- 37. Gao B, Radaeva S, and Park OJJolb. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. 2009;86(3):513–28. pmid:19542050
- 38. Holz LE, Fernandez‐Ruiz D, and Heath WR. Protective immunity to liver‐stage malaria. Clinical & translational immunology. 2016 Oct;5(10):e105
- 39. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P, Das A, Lopes AR, Borrow P, Williams K, and Humphreys E. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage. 2007;204(3):667–80. pmid:17353365
- 40. Pasquetto V, Guidotti LG, Kakimi K, Tsuji M, and Chisari FV. Host–virus interactions during malaria infection in hepatitis B virus transgenic mice. The Journal of experimental medicine. 2000;192(4):529–36. pmid:10952722
- 41. Brown AE, Mongkolsirichaikul D, Innis B, Snitbhan R, and Webster HK. Falciparum malaria modulates viremia in chronic hepatitis B virus infection. Journal of Infectious Diseases. 1992;166(6):1465–6. pmid:1431272
- 42. Sharma L, and Shukla G. Placental Malaria: A new insight into the Pathophysiology. Frontiers in medicine. 2017 Jul 25;4:117. pmid:28791290
- 43. Azizieh FY, and Raghupathy RG. Tumor necrosis factor-α and pregnancy complications: a prospective study. Medical Principles and Practice. 2015;24(2):165–70. pmid:25501617
- 44. Azizieh F, Dingle K, Raghupathy R, Johnson K, VanderPlas J, and Ansari A. Multivariate analysis of cytokine profiles in pregnancy complications. American Journal of Reproductive Immunology. 2018 Mar;79(3):e12818.